Grants and Contributions:
Title:
Natural excipients for the manufacture of sustained-release tablets by direct compression
Agreement Number:
901519
Agreement Value:
$200,000.00
Agreement Date:
Feb 1, 2018 - Mar 31, 2020
Description:
Develop a new natural extended release technology, primarily for the supplement market and responding to current market trends.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Levis, Quebec, CA G6W 0L9
Reference Number:
172-2018-2019-Q4-901519
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
811196468
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 2 time(s). The end date of this agreements has been modified by 53 days.
Amendment Date
Mar 18, 2019
Recipient's Legal Name:
Biovélia inc.
Federal Riding Name:
Bellechasse--Les Etchemins--Lévis
Federal Riding Number:
24010
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: